Evidence map›Paper›PMID 42039555›Full record

ArticlebioRxiv : the preprint server for biology2026

Psilocybin reshapes cortical inhibition through selective interneuron recruitment.

Pasha A Davoudian, Quan Jiang, Cory A Knox, Neil K Savalia, Ling-Xiao Shao, Joshua Wilson, Amanda M Weiner, Catherine W Chong, Clara Liao, Jack D Nothnagel and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pasha A DavoudianMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0002-5096-7610
Quan JiangMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0001-8201-6417
Cory A KnoxMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0009-0006-4376-2429
Neil K SavaliaMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0003-2262-4466
Ling-Xiao ShaoMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0009-0006-9503-1230
Joshua WilsonMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0002-6611-6941
Amanda M WeinerMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0002-4607-8570
Catherine W ChongMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.
Clara LiaoMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0003-2734-8202
Jack D NothnagelMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.
Takeshi SakuraiInternational Institute for Integrative Sleep Medicine, University of Tsukuba, Tsukuba, Japan.ORCID 0000-0003-4474-6253
Alex C KwanMeinig School of Biomedical Engineering, Cornell University, Ithaca, NY, 14853, USA.ORCID 0000-0003-2169-1667

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Cellular basis of psilocybin actions in frontal cortexR01MH128217 · NIMH · CORNELL UNIVERSITY · PI CHUN-HAY ALEX KWAN · 2022 to 2026
$2.9M
A Dendritic Substrate for Fast-Acting Antidepressant ActionR01MH121848 · NIMH · YALE UNIVERSITY · PI KWAN, CHUN-HAY ALEX · 2020 to 2024
$2.6M
Role of cortical GABAergic interneurons in psychedelic drug actionR01MH137047 · NIMH · CORNELL UNIVERSITY · PI CHUN-HAY ALEX KWAN · 2024 to 2026
$1.9M
Acquisition of an automated phase and fluorescence microscope for Cornell BRC Imaging FacilityS10OD032251 · OD · CORNELL UNIVERSITY · PI WILLIAMS, REBECCA M · 2022 to 2022
$229k
Subcortical targets involved in the action of psilocybin in learned and innate escape behaviorsF30DA059437 · NIDA · YALE UNIVERSITY · PI DAVOUDIAN, PASHA A · 2023 to 2025
$141k
Leveraging Rapid-Acting Antidepressants for Personalized ResponseF30MH129085 · NIMH · YALE UNIVERSITY · PI SAVALIA, NEIL · 2021 to 2023
$115k
NIDA NIH HHS F30 DA059437NIGMS NIH HHS T32 GM007205NIH HHS S10 OD032251NIMH NIH HHS F30 MH129085NIMH NIH HHS R01 MH121848NIMH NIH HHS R01 MH128217NIMH NIH HHS R01 MH137047
6 · The paper itself

Abstract

Psychedelics show therapeutic potential for treating psychiatric disorders. While studies have emphasized the roles of cortical pyramidal cells, GABAergic neurons also express serotonin receptors and are therefore likely targets of psychedelics. In this study, we determine the effect of psilocybin on the activity dynamics of major GABAergic cell types in the mouse medial frontal cortex. Psilocybin reduces the firing of somatostatin-expressing interneurons, but increases the activity of parvalbumin-expressing interneurons. This cell type-specific response is unlikely to involve vasoactive intestinal peptide-expressing interneurons. Instead, pharmacological blockade and conditional knockout experiments demonstrate that psilocybin acts on the 5-HT

Indexed as

depressiondisinhibitionGABAergic neuronsmicrocircuitpsychedelicserotonin receptor

Identifiers

PMID42039555
PMCPMC13104835

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.